comparemela.com

Latest Breaking News On - Uterine leiomyoma fibroids - Page 1 : comparemela.com

Elagolix Curbs Heavy Bleeding Linked to Uterine Leiomyomas

Elagolix sodium, an oral short-acting nonpeptide gonadotropin-releasing hormone antagonist has been approved by the FDA at a dose of 300 mg twice daily with add-back therapy for up to 24 months.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.